EuropeFX offers exposure into the three most popular Cannabis stocks in the form of CFDs.
Bloomberg
Investors have been increasingly interested in Cannabis stocks, with a larger number of countries increasingly are pushing for retail legalization.
Furthermore, the space has seen a sizable uptick of investments and global spending according to a New Frontier study.
At the end of 2020, the global cannabis market was estimated to be valued at $20.5 billion and is projected to reach upwards of $90.4 billion by 2026, according to ResearchAndMarkets.com.
The sector’s growth makes it one of the most attractive for investors in 2021 looking for new places to park cash amid a rising market.
EuropeFX understands this trend and offers exposure into the three most popular Cannabis stocks in the form of contracts-for-difference (CFDs).
Markets are pointed upwards with Cannabis stocks poised to benefit from billions in inflows into equities. The market is primarily driven by factors such as growing medical applications of Cannabis as well as increasing legalization and social acceptance of marijuana per a Vividata’s National Cannabis Consumer study.
For example, North America alone has accounted for the largest market share in the Cannabis market, culminating in increassed legalization both medical and recreational purposes.
For its part, EuropeFX’s portfolio now includes three Cannabis stock CFDs, including GW Pharmaceuticals, AbbVie Inc., and Scotts Miracle-Gro.
GW Pharmaceuticals PLC
(NASDAQ:GWPH)
GW Pharmaceuticals is a British pharmaceutical company known for its multiple sclerosis treatment product nabiximols which was the first natural Cannabis plant derivative to gain market approval in any country.
The company obtained a cultivation license from the United Kingdom Home Office, allowing the company to cultivate, possess and supply cannabis to conduct scientific research concerning medicinal uses of the plant.
AbbVie Inc.
(NASDAQ:ABBV)
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions.
Scotts Miracle-Gro
(NASDAQ:SMG)
The Scotts Miracle-Gro Company is an American multinational corporation that began selling lawn seed in 1868. The company manufactures and sells consumer lawn, garden and pest control products.
As the leading provider of nutrients, plant supplements, growing media, air filtration and lighting used for hydroponic and indoor growing, the company is unique in its ability to help people who choose to produce cannabis authorized under state-law.
Investors have been increasingly interested in Cannabis stocks, with a larger number of countries increasingly are pushing for retail legalization.
Furthermore, the space has seen a sizable uptick of investments and global spending according to a New Frontier study.
At the end of 2020, the global cannabis market was estimated to be valued at $20.5 billion and is projected to reach upwards of $90.4 billion by 2026, according to ResearchAndMarkets.com.
The sector’s growth makes it one of the most attractive for investors in 2021 looking for new places to park cash amid a rising market.
EuropeFX understands this trend and offers exposure into the three most popular Cannabis stocks in the form of contracts-for-difference (CFDs).
Markets are pointed upwards with Cannabis stocks poised to benefit from billions in inflows into equities. The market is primarily driven by factors such as growing medical applications of Cannabis as well as increasing legalization and social acceptance of marijuana per a Vividata’s National Cannabis Consumer study.
For example, North America alone has accounted for the largest market share in the Cannabis market, culminating in increassed legalization both medical and recreational purposes.
For its part, EuropeFX’s portfolio now includes three Cannabis stock CFDs, including GW Pharmaceuticals, AbbVie Inc., and Scotts Miracle-Gro.
GW Pharmaceuticals PLC
(NASDAQ:GWPH)
GW Pharmaceuticals is a British pharmaceutical company known for its multiple sclerosis treatment product nabiximols which was the first natural Cannabis plant derivative to gain market approval in any country.
The company obtained a cultivation license from the United Kingdom Home Office, allowing the company to cultivate, possess and supply cannabis to conduct scientific research concerning medicinal uses of the plant.
AbbVie Inc.
(NASDAQ:ABBV)
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions.
Scotts Miracle-Gro
(NASDAQ:SMG)
The Scotts Miracle-Gro Company is an American multinational corporation that began selling lawn seed in 1868. The company manufactures and sells consumer lawn, garden and pest control products.
As the leading provider of nutrients, plant supplements, growing media, air filtration and lighting used for hydroponic and indoor growing, the company is unique in its ability to help people who choose to produce cannabis authorized under state-law.
XBO.com Partners with Bank Frick to Deliver Comprehensive Fiat On/Off-Ramp and Corporate Banking Services
Featured Videos
FM Daily Brief - 1 May 2026
FM Daily Brief - 1 May 2026
FM Daily Brief - 1 May 2026
FM Daily Brief - 1 May 2026
iForex's CEO tells Finance Magnates the cost of their IPO delay. Also ahead: the US prediction markets legal battle splits in two, and the FCA greenlights onchain funds. It's Friday, the first of May 2026. You're listening to the Finance Magnates Daily Brief.
iForex's CEO tells Finance Magnates the cost of their IPO delay. Also ahead: the US prediction markets legal battle splits in two, and the FCA greenlights onchain funds. It's Friday, the first of May 2026. You're listening to the Finance Magnates Daily Brief.
iForex's CEO tells Finance Magnates the cost of their IPO delay. Also ahead: the US prediction markets legal battle splits in two, and the FCA greenlights onchain funds. It's Friday, the first of May 2026. You're listening to the Finance Magnates Daily Brief.
iForex's CEO tells Finance Magnates the cost of their IPO delay. Also ahead: the US prediction markets legal battle splits in two, and the FCA greenlights onchain funds. It's Friday, the first of May 2026. You're listening to the Finance Magnates Daily Brief.
Not All Video Reviews Are Created Equal | Finance Magnates
Not All Video Reviews Are Created Equal | Finance Magnates
Not All Video Reviews Are Created Equal | Finance Magnates
Not All Video Reviews Are Created Equal | Finance Magnates
Not All Video Reviews Are Created Equal | Finance Magnates
Not All Video Reviews Are Created Equal | Finance Magnates
We deliver fast, structured, neutral reviews covering regulation, platforms, leverage, payouts, and risk across brokers, prop firms, and fintech platforms.
Book your Finance Magnates video review: https://lnkd.in/dDubZJ2S
#FinanceMagnates #BrokerReview #PropTrading #Fintech #Forex #Crypto #CFD #TradingPlatforms #DigitalAssets
We deliver fast, structured, neutral reviews covering regulation, platforms, leverage, payouts, and risk across brokers, prop firms, and fintech platforms.
Book your Finance Magnates video review: https://lnkd.in/dDubZJ2S
#FinanceMagnates #BrokerReview #PropTrading #Fintech #Forex #Crypto #CFD #TradingPlatforms #DigitalAssets
We deliver fast, structured, neutral reviews covering regulation, platforms, leverage, payouts, and risk across brokers, prop firms, and fintech platforms.
Book your Finance Magnates video review: https://lnkd.in/dDubZJ2S
#FinanceMagnates #BrokerReview #PropTrading #Fintech #Forex #Crypto #CFD #TradingPlatforms #DigitalAssets
We deliver fast, structured, neutral reviews covering regulation, platforms, leverage, payouts, and risk across brokers, prop firms, and fintech platforms.
Book your Finance Magnates video review: https://lnkd.in/dDubZJ2S
#FinanceMagnates #BrokerReview #PropTrading #Fintech #Forex #Crypto #CFD #TradingPlatforms #DigitalAssets
We deliver fast, structured, neutral reviews covering regulation, platforms, leverage, payouts, and risk across brokers, prop firms, and fintech platforms.
Book your Finance Magnates video review: https://lnkd.in/dDubZJ2S
#FinanceMagnates #BrokerReview #PropTrading #Fintech #Forex #Crypto #CFD #TradingPlatforms #DigitalAssets
We deliver fast, structured, neutral reviews covering regulation, platforms, leverage, payouts, and risk across brokers, prop firms, and fintech platforms.
Book your Finance Magnates video review: https://lnkd.in/dDubZJ2S
#FinanceMagnates #BrokerReview #PropTrading #Fintech #Forex #Crypto #CFD #TradingPlatforms #DigitalAssets
FM Daily Brief - 30 April 2026
FM Daily Brief - 30 April 2026
FM Daily Brief - 30 April 2026
FM Daily Brief - 30 April 2026
FM Daily Brief - 30 April 2026
FM Daily Brief - 30 April 2026
iForex posts its first annual results as a listed broker. Also ahead: CFI Financial secures a Brazil license, and prediction markets have a big week, with new ETF launches and fresh Polymarket loss data. It's Thursday, the thirtieth of April 2026. You're listening to the Finance Magnates Daily Brief.
iForex posts its first annual results as a listed broker. Also ahead: CFI Financial secures a Brazil license, and prediction markets have a big week, with new ETF launches and fresh Polymarket loss data. It's Thursday, the thirtieth of April 2026. You're listening to the Finance Magnates Daily Brief.
iForex posts its first annual results as a listed broker. Also ahead: CFI Financial secures a Brazil license, and prediction markets have a big week, with new ETF launches and fresh Polymarket loss data. It's Thursday, the thirtieth of April 2026. You're listening to the Finance Magnates Daily Brief.
iForex posts its first annual results as a listed broker. Also ahead: CFI Financial secures a Brazil license, and prediction markets have a big week, with new ETF launches and fresh Polymarket loss data. It's Thursday, the thirtieth of April 2026. You're listening to the Finance Magnates Daily Brief.
iForex posts its first annual results as a listed broker. Also ahead: CFI Financial secures a Brazil license, and prediction markets have a big week, with new ETF launches and fresh Polymarket loss data. It's Thursday, the thirtieth of April 2026. You're listening to the Finance Magnates Daily Brief.
iForex posts its first annual results as a listed broker. Also ahead: CFI Financial secures a Brazil license, and prediction markets have a big week, with new ETF launches and fresh Polymarket loss data. It's Thursday, the thirtieth of April 2026. You're listening to the Finance Magnates Daily Brief.
FM Daily Brief - 29 April 2026
FM Daily Brief - 29 April 2026
FM Daily Brief - 29 April 2026
FM Daily Brief - 29 April 2026
FM Daily Brief - 29 April 2026
FM Daily Brief - 29 April 2026
XTB and Robinhood both post first-quarter earnings. But the numbers point in very different directions. Also ahead: Capital.com pushes into three new markets and signals a move into payments.
It's Wednesday, the 29th of April 2026. You're listening to the Finance Magnates Daily Brief.
XTB and Robinhood both post first-quarter earnings. But the numbers point in very different directions. Also ahead: Capital.com pushes into three new markets and signals a move into payments.
It's Wednesday, the 29th of April 2026. You're listening to the Finance Magnates Daily Brief.
XTB and Robinhood both post first-quarter earnings. But the numbers point in very different directions. Also ahead: Capital.com pushes into three new markets and signals a move into payments.
It's Wednesday, the 29th of April 2026. You're listening to the Finance Magnates Daily Brief.
XTB and Robinhood both post first-quarter earnings. But the numbers point in very different directions. Also ahead: Capital.com pushes into three new markets and signals a move into payments.
It's Wednesday, the 29th of April 2026. You're listening to the Finance Magnates Daily Brief.
XTB and Robinhood both post first-quarter earnings. But the numbers point in very different directions. Also ahead: Capital.com pushes into three new markets and signals a move into payments.
It's Wednesday, the 29th of April 2026. You're listening to the Finance Magnates Daily Brief.
XTB and Robinhood both post first-quarter earnings. But the numbers point in very different directions. Also ahead: Capital.com pushes into three new markets and signals a move into payments.
It's Wednesday, the 29th of April 2026. You're listening to the Finance Magnates Daily Brief.
FM Daily Brief - 28 April 2026
FM Daily Brief - 28 April 2026
FM Daily Brief - 28 April 2026
FM Daily Brief - 28 April 2026
FM Daily Brief - 28 April 2026
FM Daily Brief - 28 April 2026
Startrader posts three-point-one trillion dollars in first-quarter volume — up three hundred and forty percent from a year ago. Also ahead: Fintokei claims sub-second trader payouts, and eToro opens its premium subscription tier to all investors.
Startrader posts three-point-one trillion dollars in first-quarter volume — up three hundred and forty percent from a year ago. Also ahead: Fintokei claims sub-second trader payouts, and eToro opens its premium subscription tier to all investors.
Startrader posts three-point-one trillion dollars in first-quarter volume — up three hundred and forty percent from a year ago. Also ahead: Fintokei claims sub-second trader payouts, and eToro opens its premium subscription tier to all investors.
Startrader posts three-point-one trillion dollars in first-quarter volume — up three hundred and forty percent from a year ago. Also ahead: Fintokei claims sub-second trader payouts, and eToro opens its premium subscription tier to all investors.
Startrader posts three-point-one trillion dollars in first-quarter volume — up three hundred and forty percent from a year ago. Also ahead: Fintokei claims sub-second trader payouts, and eToro opens its premium subscription tier to all investors.
Startrader posts three-point-one trillion dollars in first-quarter volume — up three hundred and forty percent from a year ago. Also ahead: Fintokei claims sub-second trader payouts, and eToro opens its premium subscription tier to all investors.